Inflammatory Biomarkers as Potential Mediators for the Association between Periodontal and Systemic Disease in Kosovo

Abstract

The possibility of a connection between oral cavity and systemic diseases has been intensively researched in recent years. The aim of this study was to compare the serum levels of highsensitivity C reactive protein (hs-CRP), interleukin-1 beta (IL1β), interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNFα) between patients with and without periodontitis. Clinical periodontal parameters: gingival index, the dental plaque index, the probing depth, the clinical attachment level, the bleeding index and the tooth mobility index were measured at six sites per tooth in seventy-five subjects with periodontitis and in thirty-five periodontally healthy subjects. Serum levels of hs-CRP and inflammatory cytokines were assessed via Enzyme-Linked ImmunoSorbent Assay. Inter-group significance was determined by the Student’s t-test, x2-test and Mann-Whitney test. The concentrations of each biomarker (control group vs. periodontal disease group) were as follows: hsCRP (0.5 ± 0.6 vs. 2.5 ± 2.6, respectively), IL-1β (2.1 ± 2.2 vs. 7.0 ± 11.6, respectively), IL- 6 (1.9 ± 1.6 vs. 3.7 ± 4.4, respectively) and TNF- α (64.6 ± 72.3 vs. 80.0 ± 73.1, respectively). The differences between the groups showed statistical significance at p < 0.05. Periodontal disease was associated with increased circulating concentrations of hs-CRP and inflammatory cytokines. Clinical article (J Int Dent Med Res 2013; 6: (1), pp. 1-5)

Keywords

• Periodontal disease, interleukin–1 beta, interleukin–6, tumour necrosis factor alpha, high sensitivity- C reactive protein.

Inflammatory Biomarkers as Potential Mediators for the Association between Periodontal and Systemic Disease in Kosovo

Öz

Anahtar Kelimeler

• -

Kaynakça

1. Williams RC, Offenbacher S: Periodontal medicine: The emergency of a new branch of periodontology. Periodontol 2000 2000;23:9-12.
2. Ebersole JL, Machen RL, Steffen MJ, Willmann DE: Systemic acute-phase reactants, C-reactive protein and haptoglobin in adult periodontitis. Clin Exp Immunol 1997; 107(2):347-352.
3. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E: Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001; 72(9):1221-1227.
4. Kinnane DF, Lappin DF: Immune processes in periodontal disease : A review. Ann Periodontol 2001;7:62-71.
5. Buhlin K, Gustafsson A, Pockley AG, Frostegard J, Klinge B: Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J 2003; 24:2099-2107.
6. Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD. Relationship of destructive periodontal disease to the acute- phase response. J Periodontol 2003;74:1007-1016.
7. Borden EC, Chin P: Interleukin 6: a cytokine with potential diagnostic and therapeutic roles. Journal of Laboratory and Clinical Medicine 1994;123:824-829.
8. Bradley JR: TNF- mediated inflammatory disease. J Pathol 2008;214:149-160.

9. Ebersole JL, Machen RL, Steffen MJ, Willmann DE: Systemic acute-phase reactants, C-reactive protein and hatoglobin in adult periodontitis. Clin Exp Immunol 1997; 107:347-352.
10. Loos BG: Systemic markers of inflammation in periodontitis. Journal of Periodontology 2005;76:2106-2115.
11. Loe H: The gingival index, the plaque index and the retention index systems. J Periodontol 1967;38:610.
12. Silness P, Loe H: Periodontal disease in pregnancy. Acta Odontal Scand 1964;22:121.
13. Lopez NJ, Smith PC, Gutierrez S: Periodontal therapy may reduce risk of preterm low birth weight in women with periodontal disease: a randomized controlled trial. J Periodontology 2001; 73:911-924.
14. Ridker PM, Morrow DA: C-reactive protein, inflammation, and coronary risk. Cardiol Clin 2003;21:315-325.
15. Beckman JA, Preis O, Ridker PM, Gerhard Herman M: Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke and death). Am J Cardiol 2005;96:1374-1378.
16. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E: Periodontal infection contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-7.
17. Boucher NE Jr, Hanrahan JJ, Kihara FY: Occurrence of Creactive protein in oral disease. J Dent Res 1967;46:624.
18. Slade GD, Ghezzi EM, Heiss G, Beck JD, Riche E, Offenbacher S: Relationship between periodontal disease and C reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med 2003;163:1172-9.
19. Loos BG, Craandijik J, Hoek FJ, Wertheim –van Dillen PM, van der Velden U: Evaluation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000; 71:1528-34.
20. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35:277-290.
21. Engebreston SP, Lamster IB, Herrera- Abreu M, Celenti RS, Timms JM, Chaudhar AGA, Giovine F, Kornman KS: The influence of interleukin gene polymorphism on expression of interleukin-1beta and tumor necrosis factor-alpha in periodontal tissue and gingival crevicular fluid. J Periodontol 1999;70:5675
22. Hou LT, Liu CM, Rossomando EF: Cervicular interleukin 1 beta in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol 1995;22:1621
23. Marcaccini AM, Meschiari CA, Sorgi, Saraiva MCP, De Souza AM, Faccioli LH, Tanus-Santos J, Novaes AB, Gerlach RF: Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol 2009;80:594-602.
24. Persson GR, Pettersson T, Ohlsson O, Renvert S: Highsensitivity serum C-reactive protein levels in subjects with or without myocardial infarction or periodontitis. J Clin Periodontol 2005;32:219-224.
25. Albert MA: Race/ethnicity and inflammation- is there a link with periodontal disease? J Periodontol 2008;79:1121-3.